BioSig Technologies is a medical device company commercializing a digital signal processing technology platform to deliver insights to the treatment of cardiovascular arrhythmias. Co.'s first product, the PURE EP™ System, is a non-invasive class II device consisting of a combination of hardware and software designed to provide signal clarity and precision for real-time visualization of intracardiac signals paving the way for personalized patient care. Integrating with existing systems in the electrophysiology lab, PURE EP™ is designed to pinpoint signals to maximize procedural success and efficiency. We show 25 historical shares outstanding datapoints in our BSGM shares outstanding history coverage, used to compute BSGM market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing BSGM market cap history over the course of time is important for investors
interested in comparing BSGM's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of BSGM versus a peer is one thing; comparing
BSGM market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like BSGM can fluctuate over the course of history.
With this page we aim to empower investors researching BSGM by allowing them to research the BSGM market cap history. |
Free BSGM Email Alerts:
Video: The Importance of Market Cap
